A Study Assessing the Effect of Aerobic Exercise on Cancer


Full Title

Exercise as Interception Therapy: A “Proof-of-Concept” Digitized Trial


Some studies suggest that exercise may be helpful for preventing the risk that certain cancers will come back after treatment. In this study, researchers are evaluating the effects of aerobic exercise in people who have received treatment for stage 3 or 4 breast cancer or stage 3 colon cancer. They will also analyze the effects of exercise in people with clonal hematopoiesis, a blood condition that increases the risk of some blood-based cancers.

The researchers will look at how aerobic exercise changes the biomarkers (signs of disease) found in patients’ blood. Participants will be required to participate in treadmill walking sessions for about 300 minutes each week. These sessions can be completed at Memorial Sloan Kettering or at home. Participants who choose to do the exercise at home will have a treadmill, electronic tablet, and other equipment shipped to their homes, to be returned at the conclusion of the study.

Who Can Join

To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • Participants must have completed treatment for stage 3 breast or colon cancer, have stable stage 4 breast cancer not being treated with chemotherapy, or have clonal hematopoiesis.
  • This study is for patients age 18 and older.

For more information about this study and to inquire about eligibility, please contact Dr. Neil Iyengar at 646-888-8103.




Pilot (small research study)



ClinicalTrials.gov ID